The short term safety of COVID‐19 vaccines in Australia: AusVaxSafety active surveillance, February – August 2021

OBJECTIVE: To assess the short term safety of the COVID‐19 vaccines Comirnaty (Pfizer–BioNTech BNT162b2) and Vaxzevria (AstraZeneca ChAdOx1) in Australia. DESIGN: Prospective observational cohort study; online surveys by AusVaxSafety, a national active vaccine safety surveillance system, three and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Lucy, Glover, Catherine, Dymock, Michael, Pillsbury, Alexis, Marsh, Julie A, Quinn, Helen E, Leeb, Alan, Cashman, Patrick, Snelling, Thomas L, Wood, Nicholas, Macartney, Kristine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350119/
https://www.ncbi.nlm.nih.gov/pubmed/35781813
http://dx.doi.org/10.5694/mja2.51619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350119/
https://www.ncbi.nlm.nih.gov/pubmed/35781813
http://dx.doi.org/10.5694/mja2.51619

Ejemplares similares